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The British government is
bolstering legislation to curb the
activity of animal rights protesters
who threaten researchers as
pharmaceutical companies pledge
funds to support animal testing in
universities in the face of fears
that their crucial supply of
graduate and postgraduate
recruits is under threat.
A hastily assembled programme
of legislative reform was released
in response to the success of
direct action in stopping work on
a new laboratory for Oxford
University and forcing the main
contractor, Montpellier, to
abandon the project last month. 
The government responded with
a 20-page document, with a
foreword signed jointly by the
prime minister, Tony Blair, and the
home secretary, David Blunkett,
defending the use of animals in
research, which outlines attempts
to develop medical alternatives
and the need to concentrate on
sharpening the existing array of
law and order tools to defeat the
extremists.
Three new offences are
proposed to give the police power
‘to tackle protests outside homes
more effectively’ and prevent the
harassment of employees of
companies involved in the
pharmaceutical industry.
Officers should be able to arrest
anyone demonstrating outside a
house ‘in such a way that causes
‘harassment, alarm or distress to
residents.’ 
A new offence created by
amending section 42 of the
Criminal Justice and Police Act
2001 would forbid those ‘moved
on’ from returning to a house
within three months for ‘the
purpose of representing to or
persuading the resident or anyone
else, that he should not do
something he is entitled to do, or
that he should do something he is
not obliged to do.’
Expansion of the 1997
Harassment Act would make it
easier to arrest someone for
harassing as few as two
employees of a company, ‘even if
each is harassed on only one
occasion’.
The paper says that the
government has not closed the
door on a new law dealing solely
with crimes by animal rights
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The British government and pharmaceutical companies have ramped
up action against the increasing threat from animal activists but some
are still concerned they have not gone far enough to protect
researchers. Nigel Williams reports.
Animal issues: Protesters have increased opposition to a new animal research facility at Oxford University but the British Govern-
ment and the pharmaceutical industry are fighting back. (Picture: Science Photo Library.)
extremists, but adds: ‘It would not
be sensible to try to seek a
separate bill which, because of
pressures of parliamentary time,
could not be taken this year.’
Britain’s pharmaceutical giants
also responded to the growing
threat from animal rights activists
last month by launching a
£4 million research fund to pay for
animal experiments in universities.
The three multinational drug
companies with the largest
research operations in the UK,
GlaxoSmithKline, AstraZeneca
and Pfizer, said they would back
fellowships and pay for laboratory
equipment to help universities
continue animal testing in the face
of increasing hostility from
campaigners.
“This new fund will help ensure
the quality of the basic animal
research carried out in British
universities,” the three firms said.
“Discovering and developing new
medicines and vaccines is
dependent upon being able to
recruit graduates and post
graduates of the highest caliber
from higher education.”
Concerns about the power of
extremists to disrupt research
escalated last month when the
main construction group pulled
out of a contract to build a new
animal research centre for Oxford
University, after its shareholders
received threatening letters.
Cambridge dropped plans for a
primate research centre south of
the city in January.
The new fund was welcomed by
the science minister, Lord
Sainsbury. It will be administered
by the British Pharmacological
Association, which will use the
money to give grants to research
students, and support fellowships.
“In terms of new medicine
discovery, I don't there is a single
drug that hasn't at some point
been dependent on the use of
animal testing,” said a
spokesperson for the association.
More animal experiments are
carried out in Britain's universities
than in industry — 40 per cent of
the total, compared to 37 per cent
in the private sector.
The pharmaceutical companies,
which already face attacks from
animal extremists, are concerned
that they could also be hit by a
lack of trained scientists
graduating from universities.
“Being able to do this kind of
research is key to our ability to
deliver the best care to the
patient,” says Gill Samuels,
executive director of science for
Pfizer in Europe.
Drug companies are obliged by
the government to test the safety
of new products on animals
before trying them out on human
patients, but several have warned
that the growing prevalence of
animal rights activism could force
them to move their research
operations overseas. Few firms
want to give details of attacks on
their staff, but they list visits to
the home addresses of
employees, intimidating letters
and ‘telephone bombardment’ as
some of the tactics used by
campaigners.
Spurred by strong lobbying
from the drug industry, the
government announced its new
legal protection for scientists and
other workers who have faced
intimidation from groups such as
Stop Huntingdon Animal Cruelty.
“These people are committing
crimes and they should be dealt
with harshly,” the home secretary
David Blunkett said.
Scientists responded with
guarded enthusiasm to the plans
to tackle animal extremism. While
the measures were welcomed,
some pointed to gaps, such as
protection of university science
labs.
“This is the strongest statement
to date, the most comprehensive
strategy they have made,” says
Mark Matfield, executive director
of the Research Defence Society,
a group that lobbies on behalf of
scientists who use animals in their
research. “They’ve never put their
vision on the lines as clearly and
firmly as this.”
But others are worried that any
new powers may be not enough.
The Association of Medical
Research Charities, whose
members spend £600 million a
year on research in the UK, wrote
to the Home Office last month to
complain that ministers seemed to
be focusing on protecting industry
while ignoring academic
researchers and the public
funders of research.
Diana Garnham, chief executive
of the AMRC, said: “We know
universities are on the front line,
but there has been little talk about
how university research institutes
will be protected. The concern is
that universities and charities will
become soft targets for
extremists.’
Universities UK, the vice-
chancellors’ group, voiced similar
concerns. A spokesperson said:
“We hope that universities, other
publicly funded research
environments and charity
institutes will not be forgotten and
that attention will be paid to the
wider group of individuals
engaged in animal research.”
There is scepticism about how
far any changes to the law will be
effective in tackling the issue of
animal activism. Evan Harris,
member of parliament for Oxford
West said: “I’m not convinced that
they will come up with anything
very much.” He has lobbied the
government to underwrite security
costs at universities and to pay the
extra insurance of contractors who
undertake controversial projects.
Lord Winston, professor of
obstetrics and gynaecology at
Imperial College London warned:
“It is difficult to see what any
government can do that will be
truly effective — whether it is
industry or private researchers or
academic establishments that are
being targeted.”
The government has also
become embroiled in an issue of
prominent animal activists from
the US holding positions
sufficiently extreme to justify
refusal to enter the country. The
Home Office has written to a
number of US campaigners,
warning them that they may not
be allowed into the UK if they are
deemed to have made statements
inciting violence in the UK. There
is no appeal against exclusion,
although campaigners in the UK
can seek judicial reviews of Home
Office decisions.
Among those written to was
Jerry Vlasak, a California-based
surgeon and advisor to the group
leading the campaign to halt the
construction of the Oxford
laboratory. “I have every intention
to take legal advice if they do ban
me,” he said.
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